Task: Answer the multiple choice question.
Query: Which drug exhibits a -9.415\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] Cc1ccc(C(=O)N/C(=C/c2ccc(Cl)cc2)C(=O)N2CCOCC2)cc1
[b] Cc1nc(NCCc2ccc(S(N)(=O)=O)cc2)c2c3c(sc2n1)CCC3
Answer: a. Cc1ccc(C(=O)N/C(=C/c2ccc(Cl)cc2)C(=O)N2CCOCC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(C(=O)N/C(=C/c2ccc(Cl)cc2)C(=O)N2CCOCC2)cc1
Cc1ccc(C(=O)N/C(=C/c2ccc(Cl)cc2)C(=O)N2CCOCC2)cc1
N-[(E)-1-(4-chlorophenyl)-3-morpholin-4-yl-3-oxoprop-1-en-2-yl]-4-methylbenzamide